Cynthia M. Patton of Amgen Inc. Awarded 2019 Carol R. Marshall Award for Innovation in Corporate Ethics
VIENNA, VA., April 22, 2019 — The Ethics & Compliance Initiative (ECI), the nation’s oldest ethics research and best practice community, today announced that Cynthia M. Patton, Senior Vice President and Chief Compliance Officer for Amgen, Inc., has been named this year’s recipient of the Carol R. Marshall Award for Innovation in Corporate Ethics.
Each year, the prestigious Marshall Award is given to an ethics and compliance practitioner whose achievements exemplify the leadership and innovative practices modeled by the late ECI Fellows Chair Carol R. Marshall. ECI issues a call for nominations from the public and the recipient is selected by an independent committee of practitioners who represent the ethics and compliance industry.
Patton joined Amgen, Inc. in 2005 and has served in various roles throughout the organization, overseeing US commercial legal activities and acting as the lead commercial lawyer for the oncology and inflammation business units.
“As one of the world’s leading biotechnology companies with a commitment to transforming human health, we have an unwavering commitment to ethics and compliance,” said Robert A. Bradway, chairman and chief executive officer at Amgen, Inc. “Cynthia relentlessly fosters a culture where ‘doing the right thing for patients’ is the first and final consideration guiding all of our actions.”
As the leading provider of independent research about workplace integrity, ethical standards and compliance practices, with this award ECI honors the work of Carol R. Marshall for her innovative approach to applying ethics and compliance programs and her countless hours of service to non-profit organizations in the industry.
“Cynthia was selected for her creativity and innovation, and for her ability to ‘take E&C to the next level’” said Patricia J. Harned, Ph.D., Chief Executive Officer of ECI.” She is an example to others for her work in building a diverse and inclusive team, and her efforts to apply insights from behavioral science in Amgen’s compliance program.”
The 2019 Marshall Award, funded by Northrup Grumman, will be presented May 2nd, 2019 in Dallas, Texas during ECI’s annual IMPACT benchmarking conference.
Patton received her Juris Doctor from the National Law Center before embarking on a career specializing in healthcare law, serving as assistant general counsel of UniHealth, general counsel of SCAN Health Plan and staff attorney in the Division of Enforcement at the SEC.
In addition to her role at Amgen, Inc., Patton currently serves as a member of the Board of Trustees of Wildwood School, a board member at The Los Angeles Music Center and a board member at Martin Luther King, Jr. Community Hospital in Los Angeles.
For more information about the Marshall Award or the IMPACT 2019 annual conference, visit https://www.ethics.org/impact/
About the Ethics & Compliance Initiative
The Ethics & Compliance Initiative (ECI) is a non-profit organization that empowers organizations to build and sustain high-quality ethics and compliance programs. The organization provides research and a best practice community, as well as certification opportunities for ethics & compliance professionals. Through its membership, ECI represents entities across nearly every industry, located in 37 countries on six continents each dedicated to promoting the highest levels of integrity.